Maxwell PJ - Search Results

1

Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis.

Wilson C, Purcell C, Seaton A, Oladipo O, Maxwell PJ, O'Sullivan JM, Wilson RH, Johnston PG, Waugh DJ. Wilson C, et al. Among authors: maxwell pj. J Pharmacol Exp Ther. 2008 Dec;327(3):746-59. doi: 10.1124/jpet.108.143826. Epub 2008 Sep 9. J Pharmacol Exp Ther. 2008. PMID: 18780829

2

Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies.

Longley DB, Ferguson PR, Boyer J, Latif T, Lynch M, Maxwell P, Harkin DP, Johnston PG. Longley DB, et al. Clin Cancer Res. 2001 Nov;7(11):3533-9. Clin Cancer Res. 2001. PMID: 11705873

3

The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.

Longley DB, Boyer J, Allen WL, Latif T, Ferguson PR, Maxwell PJ, McDermott U, Lynch M, Harkin DP, Johnston PG. Longley DB, et al. Among authors: maxwell pj. Cancer Res. 2002 May 1;62(9):2644-9. Cancer Res. 2002. PMID: 11980662

4

The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells.

Longley DB, Latif T, Boyer J, Allen WL, Maxwell PJ, Johnston PG. Longley DB, et al. Among authors: maxwell pj. Semin Oncol. 2003 Jun;30(3 Suppl 6):3-9. doi: 10.1016/s0093-7754(03)00119-2. Semin Oncol. 2003. PMID: 12802789

5

Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

Maxwell PJ, Longley DB, Latif T, Boyer J, Allen W, Lynch M, McDermott U, Harkin DP, Allegra CJ, Johnston PG. Maxwell PJ, et al. Cancer Res. 2003 Aug 1;63(15):4602-6. Cancer Res. 2003. PMID: 12907638

6

5-Fluorouracil: identification of novel downstream mediators of tumour response.

Boyer J, Maxwell PJ, Longley DB, Johnston PG. Boyer J, et al. Among authors: maxwell pj. Anticancer Res. 2004 Mar-Apr;24(2A):417-23. Anticancer Res. 2004. PMID: 15152939 Free article.

7

HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells.

Maxwell PJ, Gallagher R, Seaton A, Wilson C, Scullin P, Pettigrew J, Stratford IJ, Williams KJ, Johnston PG, Waugh DJ. Maxwell PJ, et al. Oncogene. 2007 Nov 15;26(52):7333-45. doi: 10.1038/sj.onc.1210536. Epub 2007 May 28. Oncogene. 2007. PMID: 17533374

8

Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells.

MacManus CF, Pettigrew J, Seaton A, Wilson C, Maxwell PJ, Berlingeri S, Purcell C, McGurk M, Johnston PG, Waugh DJ. MacManus CF, et al. Among authors: maxwell pj. Mol Cancer Res. 2007 Jul;5(7):737-48. doi: 10.1158/1541-7786.MCR-07-0032. Epub 2007 Jul 2. Mol Cancer Res. 2007. PMID: 17606477

9

Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation.

Seaton A, Scullin P, Maxwell PJ, Wilson C, Pettigrew J, Gallagher R, O'Sullivan JM, Johnston PG, Waugh DJ. Seaton A, et al. Among authors: maxwell pj. Carcinogenesis. 2008 Jun;29(6):1148-56. doi: 10.1093/carcin/bgn109. Epub 2008 May 16. Carcinogenesis. 2008. PMID: 18487223

10

Multi-faceted roles for CXC-chemokines in prostate cancer progression.

Waugh DJ, Wilson C, Seaton A, Maxwell PJ. Waugh DJ, et al. Among authors: maxwell pj. Front Biosci. 2008 May 1;13:4595-604. doi: 10.2741/3025. Front Biosci. 2008. PMID: 18508531 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters